To establish whether the TROP2-PD1 iCAR could inhibit CEACAR T cell activity, T cells transduced with both the CAR and iCAR were cocultured with engineered DU145 prostate cancer cell lines. The gene discussed is TACSTD2; the disease is prostate carcinoma.